Article
KLK6‐regulated miRNA networks activate oncogenic pathways in breast cancer subtypes
8 Apr 2016
Abstract excerpt
KLK6 is expressed in normal mammary tissues and is aberrantly regulated in breast cancer. At physiological levels of expression, i.e. those found in normal mammary tissues, KLK6 acts as a tumor suppressor in human breast cancer. However, aberrant overexpression of KLK6 (i.e. 50-100-fold higher than normal), a characteristic of a subset of human breast cancers is associated with increased tumorigenicity...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
